Is Canopy Growth (TSX:WEED) Stock a Contrarian Buy at $20?

The downward spiral in the share price of Canopy Growth (TSX:WEED)(NYSE:CGC) and other pot stocks continues. What’s going on? Canada’s largest marijuana company just reported disappointing results for its most recent quarter ended September 30, 2019. Canopy Growth lost $374 million for the quarter, representing a 13% increase in losses compared to the same period last year. Management says the…

Read More

Captor Capital Announces Changes to Board of Directors

TORONTO, Nov. 12, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), an integrated cannabis company, today appointed Bryan Reyhani to the Board of Directors as an Independent Director. Mr. Reyhani has two decades of legal and business experience and has handled various investor, regulatory, financing, and corporate governance matters…

Read More

Is HEXO (TSX:HEXO) Stock a Contrarian Buy?

The high-flying cannabis sector has hit some turbulence in the past six months and investors are wondering whether the pullback has simply gone too far. Volatility in marijuana stocks is not new and investors should expect that trend to continue as the sector works through the growing pains associated with the emergence of a new industry. Analysts and investors agree…

Read More

Cannabis Stock Alert: Can Hexo (TSX:HEXO) Get Back to $5?

Cannabis stocks are getting crushed. If you’ve been waiting to jump in, this could be your best opportunity. Most analysts expect the global cannabis market to exceed $100 billion in sales by 2030. Some believe it could ultimately be worth more than $200 billion. If that’s true, the recent downturn could be a once-in-a-lifetime chance to scoop up stocks that…

Read More

Did HEXO (TSX:HEXO) Actually Sell its Cannabis Stock at $0.56?

A quick browse of HEXO’s (TSX:HEXO)(NYSE:HEXO) fiscal fourth-quarter 2019 financial results, as summarized in an earnings release on October 29, could raise some goosebumps for cannabis stock investors, especially when they get to the number $0.56 — shown as a realized net realized price on one revenue line during the last quarter. The company’s operational results were as follows: Source:…

Read More

Cannabis Investors: Aphria’s (TSX:APHA) Latest Licence Win Opens Up New Growth Opportunities

News on Monday revealed that marijuana producer Aphria (TSX:APHA)(NYSE:APHA) has finally obtained its long-awaited grow licences from Health Canada at its biggest facility in a development that allows the firm to double its annual production capacity to 255,000 kilograms of pot next year. The stock price didn’t respond positively to the announcement. The share price actually declined during the day.…

Read More

Has Aurora (TSX:ACB) Finally Passed Canopy Growth (TSX:WEED) as the Cannabis Industry Leader?

For many cannabis investors, the goal is to own the industry leader, as it is sure to reward you with great profits down the road. The cannabis industry is one that’s finding its feet slowly, but when it’s established, it has the chance to bring great profits to participating companies, especially to those that lead the industry. Since day one,…

Read More

3 Reasons “Cannabis 2.0” Is Ridiculously Overrated

This past October, “Cannabis 2.0” was all the rage, as speculation circulated about how the legalization of edibles and concentrates would affect cannabis producers. The new laws impact a number of product categories that were previously illegal to sell — even with the federal legalization of cannabis last year. When cannabis was initially legalized, marijuana producers’ revenue exploded on the…

Read More

Should You Buy Aurora Cannabis (TSX:ACB) Stock at $5?

The meltdown in the share prices of Canada’s top marijuana stocks has investors wondering which cannabis stock might be the best pick right now for a contrarian investment. Let’s take a look and the current situation in the market and see if Aurora Cannabis (TSX:ACB)(NYSE:ACB) deserves to be on your contrarian buy list. Growing pains The marijuana industry is still…

Read More

Could Canopy Growth (TSX:WEED) Still Hit $1 Billion in Sales?

This past January, Canopy Growth’s (TSX:WEED)(NYSE:CGC) biggest investor, Constellation Brands, said that they expected the company to reach $1 billion in revenue no later than 2020. Citing the company’s fast revenue growth, they believed it was only a matter of time before the company hit the billion-dollar sales club. However, after posting a series of disappointing quarterly reports, Canopy’s sales forecast has…

Read More